Loading…
The Chemours Company is projected to rise to $28.55 by 2027, a +27% move from its current price of $22.50. CC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.75 | $22.51 | $23.30 | +0.06% |
| May 30 | $21.46 | $22.53 | $23.65 | +0.12% |
| May 31 | $21.24 | $22.54 | $23.92 | +0.18% |
| Jun 1 | $21.06 | $22.55 | $24.16 | +0.24% |
| Jun 2 | $20.90 | $22.57 | $24.37 | +0.30% |
| Jun 3 | $20.76 | $22.58 | $24.56 | +0.36% |
| Jun 4 | $20.63 | $22.59 | $24.74 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.63 | $22.59 | $24.74 | +0.42% |
| Week 2 | $19.95 | $22.69 | $25.80 | +0.84% |
| Week 3 | $19.46 | $22.78 | $26.67 | +1.26% |
| Week 4 | $19.08 | $22.88 | $27.44 | +1.68% |
| Week 5 | $18.75 | $22.97 | $28.15 | +2.10% |
| Week 6 | $18.47 | $23.07 | $28.82 | +2.53% |
| Week 7 | $18.21 | $23.17 | $29.46 | +2.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
The Chemours Company is a Basic Materials company that provides performance chemicals across North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Through these segments, it offers refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under Freon and Opteon; TiO2 pigment under Ti-Pure; and membranes, industrial resins, additives, films, and coatings under the Teflon, Viton, Krytox, and Nafion brands.
The company sells its products through direct and indirect channels, as well as a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
The Chemours Company (CC) is a basic materials stock with a global footprint. It trades at the price of $21.37 and has a market capitalization of $3.21B, ranking 1663 by market size. The current price is supported by a near-term outlook that shows a 2026 average of $21.37 with a 0% ROI and Neutral sentiment.
In the longer term, the forecast points to a bullish trajectory, with the 2030 average price projected at $51.22 and a 139.7% ROI, and the 2040 average price at $152.21 with a 612.2% ROI. By 2050, the average is forecast at $276.75 with a 1195% ROI, underscoring a strong long-run upside.
A major floor 33.4% below — a decisive break under it would weaken the trend.
The nearest floor, 5.0% below — buyers have tended to step in here.
The nearest ceiling, 24.2% above — a clean break opens room to run.
A major ceiling 35.6% above — clearing it would confirm fresh momentum.
Key CC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.94 | Buy | $22.21 | Buy |
| MA 10 | $22.75 | Sell | $22.67 | Sell |
| MA 20 | $24.14 | Sell | $23.25 | Sell |
| MA 50 | $22.93 | Sell | $22.52 | Sell |
| MA 100 | $19.88 | Buy | $20.46 | Buy |
| MA 200 | $16.85 | Buy | $18.31 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.18 | Neutral |
| Stoch RSI (14) | 40.26 | Neutral |
| CCI (20) | -57.78 | Neutral |
| Williams %R (14) | -70.95 | Info |
| MACD (12,26,9) | -0.40 | Sell |
| ROC (12) | -2.34 | Sell |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 29.05 | Neutral |
| TRIX (15) | -0.00 | Sell |
| Awesome (5,34) | -2.11 | Sell |
| Ultimate (7,14,28) | 43.51 | Neutral |
| Momentum (10) | -2.17 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 21.57 | Buy |
| ADX (14) | 19.85 | Neutral |
| ATR (14) | 0.78 | Info |
The 30-day technical picture shows a bullish tilt with momentum supported by an RSI of 40. The 50-day simple moving average sits at $22.75, above the current price, while the 200-day moving average sits at $16.75. The price faces a near-term anchor at $21.37 of support and a resistance at $27.94, placing the stock within a defined trading range.
Over the past month, the stock traded between $16.90 and $27.02, illustrating a wide swing yet remaining within a constructive pattern for a next move higher.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.25 | $22.50 | $31.07 | 0% | Neutral | |
| $22.07 | $28.55 | $39.43 | +27% | Bullish | |
| $24.71 | $33.09 | $47.72 | +47% | Bullish | |
| $28.33 | $39.09 | $58.33 | +74% | Bullish | |
| $38.43 | $54.44 | $83.58 | +142% | Bullish | |
| $43.43 | $63.05 | $99.24 | +180% | Bullish | |
| $47.13 | $70.00 | $112.66 | +211% | Bullish | |
| $52.90 | $80.27 | $131.84 | +257% | Bullish | |
| $53.08 | $82.24 | $137.60 | +266% | Bullish | |
| $54.96 | $86.85 | $147.83 | +286% | Bullish | |
| $96.02 | $166.29 | $304.10 | +639% | Bullish | |
| $150.23 | $306.46 | $621.52 | +12.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $12.25 | $22.50 | $26.44 | +0.00% |
| June 2026 | $19.38 | $22.88 | $27.76 | +1.70% |
| July 2026 | $19.90 | $23.75 | $29.31 | +3.81% |
| August 2026 | $19.55 | $23.53 | $29.40 | -0.94% |
| September 2026 | $19.38 | $23.48 | $29.65 | -0.20% |
| October 2026 | $20.10 | $24.52 | $31.25 | +4.40% |
| November 2026 | $20.22 | $24.80 | $31.88 | +1.18% |
| December 2026 | $19.45 | $23.99 | $31.07 | -3.28% |
Click any year to see its month-by-month CC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CC is projected to trade between $12.25 and $31.07, averaging $22.50 — a potential gain of 0% from today's $22.50. A consolidation phase looks the most probable path here.
The Chemours Company's 2027 outlook centres on $28.55, within a $22.07 to $39.43 range. That is up +27% on the projected 2026 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2028, CC could reach as high as $47.72, with a base case around $33.09 and support toward $24.71 — roughly +47% from $22.50. Buyers look set to stay in control over this stretch.
Expect CC to range from $28.33 to $58.33 through 2029. The $39.09 average target implies a +74% move from current prices. That is up +18% on the projected 2028 average. Momentum favours further upside here.
The CC price prediction for 2030 points to an average of $54.44 (low $38.43, high $83.58) — a potential gain of +142% on today's $22.50. Buyers look set to stay in control over this stretch.
In 2031, CC is projected to trade between $43.43 and $99.24, averaging $63.05 — a potential gain of +180% from today's $22.50. That is up +16% on the projected 2030 average. Momentum favours further upside here.
The Chemours Company's 2032 outlook centres on $70.00, within a $47.13 to $112.66 range. That is up +11% on the projected 2031 average. That marks a +211% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CC could reach as high as $131.84, with a base case around $80.27 and support toward $52.90 — roughly +257% from $22.50. Momentum favours further upside here.
Expect CC to range from $53.08 to $137.60 through 2034. The $82.24 average target implies a +266% move from current prices. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CC price prediction for 2035 points to an average of $86.85 (low $54.96, high $147.83) — a potential gain of +286% on today's $22.50. Momentum favours further upside here.
In 2040, CC is projected to trade between $96.02 and $304.10, averaging $166.29 — a potential gain of +639% from today's $22.50. That is up +91% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The Chemours Company's 2050 outlook centres on $306.46, within a $150.23 to $621.52 range. That is up +84% on the projected 2040 average. That marks a +12.6x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CC today (≈ 44.444444 CC) could be worth
$13,620.4
+$12,620.4 (+1262%) by 2050 · US Dollar
Based on the average projected CC price of $306.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCwould be worth at today's price.
$1,000 invested in CC on May 27, 2025 (≈ 94.16196 CC) would be worth
$2,118.64
+$1,118.64 (+111.9%) today · 2.12× · US Dollar
Based on a CC entry price of $10.62 vs. today's $22.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.27 | $1,010.33 | +1.0% |
| 1 month ago | $26.48 | $849.7 | -15.0% |
| 3 months ago | $17.32 | $1,299.08 | +29.9% |
| 6 months ago | $12.79 | $1,759.19 | +75.9% |
| 1 year ago | $10.62 | $2,118.64 | +111.9% |
| All time (5.0y) ago | $37.37 | $602.09 | -39.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CC forecast.
Our base-case forecast reaches $45.00 around 2030.
Implied market cap at $45.00: $6.77B
The year-by-year forecast paints a strong multi-year uptrend. The 2027 average is projected at $27.04 with a 26.5% ROI and bullish sentiment, followed by 2028 at $31.03 with a 45.2% ROI and bullish tone, and 2029 at $36.35 with a 70.1% ROI.
Looking further, 2030 is seen at an average of $51.22 with a 139.7% ROI and bullish sentiment; 2031 at $58.75 with a 174.9% ROI; 2032 at $65.04 with a 204.4% ROI; 2033 at $75.24 with a 252.1% ROI; 2034 at $75.50 with a 253.3% ROI; and 2035 at $79.45 with a 271.8% ROI.
The forecast continues to 2040, with an average of $152.21 and a 612.2% ROI, and 2050 at $276.75 with a 1195% ROI. All of these years carry bullish sentiment, reflecting a long-run upside despite inherent uncertainty and volatility (annualized volatility is 70%).
Tap a question to reveal the answer.
Avg $51.22; min $35.83; max $79.38; ROI 139.7%; sentiment BULLISH.
The long-run forecast is bullish, with rising averages and high ROI from 2027 onward, including 2040 Avg $152.21 with ROI 612.2% and 2050 Avg $276.75 with ROI 1195%.
Yes. The forecast max prices reach $105.81 in 2032 and rise further, e.g., $124.96 in 2033 and $282.16 in 2040.
Current price is $21.37 and market capitalization is $3.21B.
Avg $152.21; min $86.22; max $282.16; ROI 612.2%; sentiment BULLISH.
The Chemours Company Community Discussion
0Share your The Chemours Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.